VITOL-140, injekcinis tirpalas
VITOL-140, injekcinis tirpalas
Authorised
- Retinol palmitate
- Colecalciferol
- ALPHATOCOPHEROL ACETATE
Product identification
Medicine name:
VITOL-140, injekcinis tirpalas
Active substance:
- Retinol palmitate
- Colecalciferol
- ALPHATOCOPHEROL ACETATE
Target species:
-
Dog
-
Cat
-
Cattle
-
Cattle (calf)
-
Sheep
-
Goat
-
Horse
-
Pig
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Retinol palmitate80000.00international unit(s)1.00millilitre(s)
-
Colecalciferol40000.00international unit(s)1.00millilitre(s)
-
ALPHATOCOPHEROL ACETATE20.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Cat
-
-
Intramuscular use
-
Cattle
-
Meat and offal234day
-
Milk120hour120 hours or 5 days.
-
-
Cattle (calf)
-
Meat and offal234day
-
-
Sheep
-
Meat and offal185day
-
Milk120hour120 hours or 5 days.
-
-
Goat
-
Meat and offal185day
-
Milk120hour120 hours or 5 days.
-
-
Horse
-
Meat and offal234day
-
-
Pig
-
Meat and offal224day
-
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA11JA
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Interchemie werken De Adelaar LT UAB
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/10/2004/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV2004.pdf
Lithuanian (PDF)
Download Published on: 4/07/2022
How useful was this page?: